Ana Nordberg is a former practicing lawyer with a strong interest in science and technology. Her research concerns primarily Patent Law in the pharmaceutical and health sector. Generaly, Ana Nordberg's interrests extend to the multi-layered and multifaceted intersections between the legal, ethical, social and economic aspects of emerging technologies.
Identifying legal challenges brought by synthetic biology; possible venues for integrating this emerging technology into the existing legal framework; and suggest alternative innovative approaches if necessary.
The objective is to map potential legal challenges of synthetic biology and debate selected legal issues that show greater practical relevance for the European and Danish synthetic biology community and society at large.
In particular: (a) interrogations concerning the usefulness of the current regulatory framework concerning this emerging technological field; and (b) the use of open innovation solutions or alternative intellectual property rights protection, and how to consolidate and coordinate such models with technology transfer to an industrial setting.
Primary fields of research
- Emerging Technologies Law and regulations
- European Patent Law
- Intellectual Property Law
- Competition Law
- Comparative European and USA Law
Fields of interest
- Nanotechnology, Synthetic Biology, Biotechnology
- Pharmaceutical, Medical and Health Law
- Law and Technology
- Law and Ethics
- Law and Economics
Why did you choose to work with synthetic biology?
I have always been fascinated with science and technology and at the same time painfully aware of the knowledge gap between different areas of science. Interdisciplinarity is necessary. The normative framework, i.e. the laws and rules, must be developed side by side and in close connection with scientific progress.
How would you like your work to be applied?
I hope my work will help shed some light into how to apply existing laws and regulations to emerging technologies. Simultaneously, I try to contribute to general policy debates on how to improve laws and regulations to face the challenges of emerging technologies.
Do you collaborate with other researchers?
I collaborate with several researchers from different disciplines and look forward to expand further my network.
Do you collaborate with industry?
At our Centre we aim to maintain regular contact with stakeholders and lawyers and jurists working in the field. It is very important to us to disseminate our work and debate legal issues with those facing legal challenges first hand, e.g. innovative companies and research institutions, administrative authorities, patients and consumers groups and other interest organizations. In this sense, we organize and participate in different events. See centre homepage here ...>
How do you benefit from your collaborations both within and outside science?
Collaborative work gives me a better understanding of social phenomena and scientific developments and allows me to leave my disciplinary bubble. The contact with new ideas and different perspectives increases my creativity and the ability to think ‘outside the box’.
What motivates you in your work?
As a legal scholar, I am able to contribute with analysis, reflection and news ideas to develop and improve the existing set of rules. There is nothing more fun and exciting than constantly learning new things and sharing it with others.
What accomplishment are you most proud of?
I fell my hard work has payed off every time someone has been inspired or benefited from my work in any way. I hope this will be the case with my recent book: Patenting Nanomedicine in Europe: Applying the 'medical methods exception' to emerging technologies (DJØF Publishing, 2017).
When not doing science; how do you like to spend your time?
Outdoor, preferably by the sea. With family, friends, and/or with a good book.